IPO registrations (S-1, F-1) · Registrants
Quoin Pharmaceuticals Ltd.
- SEC CIK
- 1671502 · filings on EDGAR ↗
- Name on the registration
- Quoin Pharmaceuticals, Ltd.
- Former names
- Quoin Pharmaceuticals, Ltd. (2021–2026); Cellect Biotechnology Ltd. (2016–2021); Cellect Biomed Ltd. (2016–2016)
- Registration
- Form F-1, S-1, first filed 2016-07-07, last 2024-12-18; 8 initial registrations, 12 amendments
- Outcome
- Final prospectus filed 2016-08-01; declared effective 2016-07-28; withdrawal requested 2016-08-03
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- L3
- Business address
- 42127 PLEASANT FOREST COURT, Ashburn, VA 20148-7349
- Ticker
- QNRX (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- Quoin Pharmaceuticals Ltd. on the corporate pages
On this site
- Business registration: Quoin Pharmaceuticals, Inc. Fuzzy (name and state)
- Form D issuer: Quoin Pharmaceuticals Ltd. EXACT (CIK (EXACT))
- Lobbying client: QUOIN PHARMACEUTICALS, INC. Fuzzy (name and state)
- SEC filer: Quoin Pharmaceuticals, Ltd. EXACT (CIK (EXACT))
Filings 50
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2016-07-07 | F-1 | F-1 (foreign registration) | Cellect Biomed Ltd. | 0001144204-16-112021 ↗ |
| 2016-07-22 | F-1/A | F-1/A (amendment) | Cellect Biotechnology Ltd. | 0001144204-16-114015 ↗ |
| 2016-07-25 | F-1/A | F-1/A (amendment) | Cellect Biotechnology Ltd. | 0001144204-16-114170 ↗ |
| 2016-07-26 | F-1/A | F-1/A (amendment) | Cellect Biotechnology Ltd. | 0001144204-16-114563 ↗ |
| 2016-07-27 | F-1/A | F-1/A (amendment) | Cellect Biotechnology Ltd. | 0001144204-16-114741 ↗ |
| 2016-07-28 | F-1/A | F-1/A (amendment) | Cellect Biotechnology Ltd. | 0001144204-16-114929 ↗ |
| 2016-07-28 | EFFECT | EFFECT (declared effective) | Cellect Biotechnology Ltd. | 9999999995-16-005275 ↗ |
| 2016-08-01 | 424B4 | 424B4 (final prospectus) | Cellect Biotechnology Ltd. | 0001144204-16-115454 ↗ |
| 2016-08-03 | RW | RW (withdrawal request) | Cellect Biotechnology Ltd. | 0001019155-16-000662 ↗ |
| 2017-04-06 | EFFECT | EFFECT (declared effective) | Cellect Biotechnology Ltd. | 9999999995-17-000744 ↗ |
| 2017-08-09 | EFFECT | EFFECT (declared effective) | Cellect Biotechnology Ltd. | 9999999995-17-002066 ↗ |
| 2017-08-17 | EFFECT | EFFECT (declared effective) | Cellect Biotechnology Ltd. | 9999999995-17-002148 ↗ |
| 2017-12-28 | F-1 | F-1 (foreign registration) | Cellect Biotechnology Ltd. | 0001213900-17-013701 ↗ |
| 2018-02-06 | F-1/A | F-1/A (amendment) | Cellect Biotechnology Ltd. | 0001213900-18-001352 ↗ |
| 2018-02-08 | EFFECT | EFFECT (declared effective) | Cellect Biotechnology Ltd. | 9999999995-18-000371 ↗ |
| 2018-04-06 | EFFECT | EFFECT (declared effective) | Cellect Biotechnology Ltd. | 9999999995-18-000768 ↗ |
| 2018-08-21 | EFFECT | EFFECT (declared effective) | Cellect Biotechnology Ltd. | 9999999995-18-002155 ↗ |
| 2018-12-28 | F-1 | F-1 (foreign registration) | Cellect Biotechnology Ltd. | 0001213900-18-017985 ↗ |
| 2019-01-24 | F-1/A | F-1/A (amendment) | Cellect Biotechnology Ltd. | 0001213900-19-001174 ↗ |
| 2019-02-07 | F-1/A | F-1/A (amendment) | Cellect Biotechnology Ltd. | 0001213900-19-001810 ↗ |
| 2019-02-07 | EFFECT | EFFECT (declared effective) | Cellect Biotechnology Ltd. | 9999999995-19-000126 ↗ |
| 2019-02-11 | 424B4 | 424B4 (final prospectus) | Cellect Biotechnology Ltd. | 0001213900-19-002116 ↗ |
| 2019-04-04 | EFFECT | EFFECT (declared effective) | Cellect Biotechnology Ltd. | 9999999995-19-000619 ↗ |
| 2021-08-12 | EFFECT | EFFECT (declared effective) | Cellect Biotechnology Ltd. | 9999999995-21-003177 ↗ |
| 2022-04-15 | F-1 | F-1 (foreign registration) | Quoin Pharmaceuticals, Ltd. | 0001410578-22-000921 ↗ |
| 2022-04-22 | EFFECT | EFFECT (declared effective) | Quoin Pharmaceuticals, Ltd. | 9999999995-22-001069 ↗ |
| 2022-06-30 | RW | RW (withdrawal request) | Quoin Pharmaceuticals, Ltd. | 0001104659-22-076351 ↗ |
| 2022-08-03 | F-1 | F-1 (foreign registration) | Quoin Pharmaceuticals, Ltd. | 0001410578-22-002024 ↗ |
| 2022-08-04 | F-1/A | F-1/A (amendment) | Quoin Pharmaceuticals, Ltd. | 0001410578-22-002035 ↗ |
| 2022-08-05 | F-1MEF | F-1MEF (added securities) | Quoin Pharmaceuticals, Ltd. | 0001104659-22-086492 ↗ |
| 2022-08-05 | EFFECT | EFFECT (declared effective) | Quoin Pharmaceuticals, Ltd. | 9999999995-22-002284 ↗ |
| 2022-08-09 | 424B4 | 424B4 (final prospectus) | Quoin Pharmaceuticals, Ltd. | 0001410578-22-002138 ↗ |
| 2023-02-03 | S-1 | S-1 (registration) | Quoin Pharmaceuticals, Ltd. | 0001410578-23-000057 ↗ |
| 2023-02-09 | S-1/A | S-1/A (amendment) | Quoin Pharmaceuticals, Ltd. | 0001410578-23-000082 ↗ |
| 2023-02-10 | EFFECT | EFFECT (declared effective) | Quoin Pharmaceuticals, Ltd. | 9999999995-23-000380 ↗ |
| 2023-02-23 | 424B4 | 424B4 (final prospectus) | Quoin Pharmaceuticals, Ltd. | 0001410578-23-000149 ↗ |
| 2023-03-17 | EFFECT | EFFECT (declared effective) | Quoin Pharmaceuticals, Ltd. | 9999999995-23-000604 ↗ |
| 2024-02-12 | S-1 | S-1 (registration) | Quoin Pharmaceuticals, Ltd. | 0001410578-24-000039 ↗ |
| 2024-02-13 | S-1/A | S-1/A (amendment) | Quoin Pharmaceuticals, Ltd. | 0001410578-24-000043 ↗ |
| 2024-02-14 | EFFECT | EFFECT (declared effective) | Quoin Pharmaceuticals, Ltd. | 9999999995-24-000474 ↗ |
| 2024-03-06 | 424B4 | 424B4 (final prospectus) | Quoin Pharmaceuticals, Ltd. | 0001410578-24-000142 ↗ |
| 2024-04-03 | EFFECT | EFFECT (declared effective) | Quoin Pharmaceuticals, Ltd. | 9999999995-24-000842 ↗ |
| 2024-12-11 | S-1 | S-1 (registration) | Quoin Pharmaceuticals, Ltd. | 0001104659-24-127623 ↗ |
| 2024-12-18 | S-1/A | S-1/A (amendment) | Quoin Pharmaceuticals, Ltd. | 0001104659-24-129745 ↗ |
| 2024-12-20 | EFFECT | EFFECT (declared effective) | Quoin Pharmaceuticals, Ltd. | 9999999995-24-003894 ↗ |
| 2024-12-23 | 424B4 | 424B4 (final prospectus) | Quoin Pharmaceuticals, Ltd. | 0001104659-24-131090 ↗ |
| 2025-04-03 | EFFECT | EFFECT (declared effective) | Quoin Pharmaceuticals, Ltd. | 9999999995-25-000961 ↗ |
| 2025-12-04 | EFFECT | EFFECT (declared effective) | Quoin Pharmaceuticals, Ltd. | 9999999995-25-003536 ↗ |
| 2026-09-25 | EFFECT | EFFECT (declared effective) | Quoin Pharmaceuticals Ltd. | 9999999995-26-003071 ↗ |
| 2026-11-04 | EFFECT | EFFECT (declared effective) | Quoin Pharmaceuticals Ltd. | 9999999995-26-003443 ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Carter Denise P. | Director,Officer | Chief Operating Officer | 9 | 2023–2026 | |
| Cooper Joseph Patrick | Director | 6 | 2023–2026 | ||
| Culverwell Anthony James | Director | 10 | 2023–2026 | ||
| Dunn Gordon | Officer | Chief Financial Officer | 5 | 2023–2024 | |
| LANGER DENNIS | Director | 10 | 2023–2026 | ||
| Leong Natalie Ee Mun | Director | 7 | 2023–2026 | ||
| Myers Michael | Director,Officer | Chief Executive Officer | 9 | 2023–2026 | |
| SEMBER MICHAEL T | Director | 5 | 2023–2026 | ||
| Lawlor Sally Bridget | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 4 | 2025–2026 | |
| Stonepine Capital Management, LLC | TenPercentOwner | 2 | 2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2026-09-10 | Quoin Pharmaceuticals Ltd. | Pharmaceuticals | $50,000,649 | $50,000,649 | 33 | 1 |
| 2025-10-23 | Quoin Pharmaceuticals, Ltd. | Pharmaceuticals | $105,254,891 | $105,254,891 | 27 | 1 |
| 2022-08-31 | Quoin Pharmaceuticals, Ltd. | Pharmaceuticals | $193,537 | $193,537 | 1 | 1 |
| 2018-02-09 | Cellect Biotechnology Ltd. | Pharmaceuticals | $3,999,996 | $3,999,996 | 3 | 1 |
| 2017-09-19 | Cellect Biotechnology Ltd. | Pharmaceuticals | $4,303,000 | $4,302,202 | 18 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.